Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions

被引:7
|
作者
Klemencic Kozul, Tara [1 ]
Yudina, Anna [2 ]
Donovan, Carley [1 ]
Pinto, Ashwin [1 ]
Osman, Chinar [1 ]
机构
[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[2] Terumo Blood & Cell Technol Europe, Zaventem, Belgium
关键词
Plasma exchange (PLEX); Intravenous immunoglobulin (IVIg); Cost-minimisation; Autoimmune neurological disorders; Cost effectiveness; INTRAVENOUS IMMUNOGLOBULIN; ADVERSE EVENTS; PLASMAPHERESIS; COMPLICATIONS; SAFETY; GUIDELINES; APHERESIS; THERAPY; UPDATE; TRIAL;
D O I
10.1186/s12913-022-08210-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Plasma exchange (PLEX) is an effective treatment for antibody-mediated neurological disorders and has been shown to be equally efficacious to intravenous immunoglobulin (IVIg) with comparable adverse event profiles. IVIg has traditionally been the preferred treatment option due to its ease of use. However, advancing technology has allowed PLEX to be performed with a centrifugal system via peripheral access as opposed to central access via a membrane filter. Methods We prospectively collected data from a cohort of patients who underwent PLEX at the Wessex Neurological Centre, UK, to perform a cost-minimisation analysis comparing PLEX to IVIg, the standard of care, between May 2019 and May 2020. Data obtained included indication, admission type (inpatient, daycase or intensive care), access (peripheral or central), number of PLEX cycles, exchange volume, patient weight, complications and clinical outcomes. The cost of PLEX delivered in an outpatient setting for an average 80kg person was calculated and compared to the equivalent cost of delivering IVIg by means of a cost-minimization model. Results The provision of PLEX was roughly half as costly when compared to what it would have been for IVIg (886 pound per exchange vs 1778 pound per infusion or 4432 pound per cycle of 5 exchanges vs 8890 pound per cycle of 5 infusions). Our cohort included a total of 44 patients who received a total of 357 PLEX exchanges during the 12-month period (the majority of which were in a daycase setting). We calculated an annual cost saving for PLEX over IVIg of 318,589 pound. The robustness of this result was confirmed by a one-way deterministic sensitivity analysis, showing the cost-effectiveness of PLEX. Conclusion Our findings demonstrate that PLEX is more cost-effective than IVIg in this setting. Our study supports the economic case for development of plasma exchange centres in regional neurology units, a case made all the more relevant in the context of constrained supplies of IVIg.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions
    Tara Klemencic Kozul
    Anna Yudina
    Carley Donovan
    Ashwin Pinto
    Chinar Osman
    BMC Health Services Research, 22
  • [2] Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease
    Nieto-Aristizabal, Ivana
    Vivas, Alvaro J.
    Ruiz-Montano, Pablo
    Aragon, Cristian C.
    Posso-Osorio, Ivan
    Quinones, Jairo
    Rivillas, Julian Alejandro
    Tobon, Gabriel J.
    AUTOIMMUNE DISEASES, 2020, 2020
  • [3] Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain
    B Ojeda
    L M de Sande
    A Casado
    P Merino
    M A Casado
    British Journal of Cancer, 2003, 89 : 1002 - 1007
  • [4] Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain
    Ojeda, B
    de Sande, LM
    Casado, A
    Merino, P
    Casado, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 1002 - 1007
  • [5] Cost-minimisation analysis of polysomnography and pulse oximetry in a risk stratification protocol for paediatric adenotonsillectomy
    Key, Seraphina
    Chia, Clemente
    Nixon, Gillian
    Paddle, Paul
    ANZ JOURNAL OF SURGERY, 2022, 92 (09) : 2292 - 2298
  • [6] Cost-minimisation analysis of vaginal wall repair in an inpatient or outpatient regimen
    Sorensen, Jan
    Axelsen, Susanne Maigaard
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2007, 86 (04) : 473 - 479
  • [7] Cost-Minimisation Analysis in First-Line Treatment of Metastatic Colorectal Cancer in France: XELOX versus FOLFOX-6
    Perrocheau, G.
    Bennouna, J.
    Ducreux, M.
    Hebbar, M.
    Ychou, M.
    Lledo, G.
    Conroy, T.
    Dominguez, S.
    Faroux, R.
    Florentin, V.
    Douillard, J. Y.
    ONCOLOGY, 2010, 79 (3-4) : 174 - 180
  • [8] Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases
    Boedecker, Simone C.
    Luessi, Felix
    Engel, Sinah
    Kraus, Daniel
    Klimpke, Pascal
    Holtz, Stefan
    Meinek, Myriam
    Marczynski, Paul
    Weinmann, Arndt
    Weinmann-Menke, Julia
    JOURNAL OF CLINICAL APHERESIS, 2022, 37 (01) : 70 - 81
  • [9] Teleconsultation in remote care stations: Cost-Minimisation analysis of the Guianese experiment
    Nassiri, N.
    Le Goff-Pronost, M.
    Nassiri, A.
    INTERNATIONAL JOURNAL OF BIOMEDICAL ENGINEERING AND TECHNOLOGY, 2009, 2 (01) : 74 - 87
  • [10] Therapeutic Plasma Exchange in Neurological Conditions: An Observation from the Eastern Part of India
    Mishra, Ajit
    Sahoo, Srikant
    Kanungo, Girijanandini
    Sahoo, Lulup
    Mishra, Shubhankar
    Mishra, Chandraprava
    ANNALS OF AFRICAN MEDICINE, 2024, 23 (04) : 649 - 655